A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with ...

A newly published review article highlights the critical role of fatty acid metabolism in shaping the tumor microenvironment and influencing cancer progression, offering fresh perspectives for the ...

Pilot study finds partial B-cell depletion restores DMARD responsiveness ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

A new study developed a mineralized DNA hydrogel that combines immune regulation with sustained bone regeneration. Using ...

At age 49, Jan Janisch-Hanzlik's multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her ...

Gram-stained section of a macrophage with ingested S epidermidis bacteria, seen as purple granules within its cytoplasm. In this stain, the nucleus appears pale, with a reddish nucleolus. It is ...

This Scientific Reports Collection welcomes original research on Metabolic reprogramming in immune-mediated disorders. Narrative review articles are also welcomed, to our sister journal Scientific ...

Amyotrophic lateral sclerosis (ALS) is marked by relentless motor neuron loss, but the disease also comes with a deeper immune imbalance. At the heart of this dysregulation is a breakdown in ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...